Published in Dig Dis Sci on April 01, 2003
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis. Eur J Cancer (2012) 1.01
Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis. World J Gastroenterol (2004) 0.93
Immunotherapy for liver tumors: present status and future prospects. J Biomed Sci (2009) 0.92
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα. Invest New Drugs (2012) 0.86
Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr (2014) 0.85
A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798). Invest New Drugs (2007) 0.82
Electroacupuncture stimulates remodeling of extracellular matrix by inhibiting apoptosis in a rabbit model of disc degeneration. Evid Based Complement Alternat Med (2015) 0.78
Induction of apoptosis in mussel Mytilus galloprovincialis gills by model cytotoxic agents. Ecotoxicology (2011) 0.76
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72
The p53 tumour suppressor gene. Nature (1991) 14.49
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell (1993) 12.02
Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene (1994) 7.24
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res (1995) 6.66
The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med (1997) 6.41
Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (1991) 6.16
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (1991) 6.04
Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol (1994) 2.57
Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene (1994) 2.49
The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo. Nat Med (1995) 1.90
Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology (2001) 1.46
Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Br J Cancer (2000) 1.01
Downregulation of proapoptotic proteins Bax and Bcl-X(S) in p53 overexpressing hepatocellular carcinomas. Biochem Biophys Res Commun (2000) 0.94
Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol (1999) 0.87
Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression. Lab Invest (1997) 0.85
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83
MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol (2012) 2.03
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology (2010) 1.77
Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol (2011) 1.65
Lifestyle risk factors for intrahepatic stone: findings from a case-control study in an endemic area, Taiwan. J Gastroenterol Hepatol (2007) 1.41
Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog (2010) 1.27
Clinicopathological analysis of cystic duct carcinoma. Hepatogastroenterology (2005) 1.13
Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis. Am J Surg (2012) 1.13
Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol (2004) 1.09
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest (2004) 1.09
Surgical management of gallbladder sarcomatoid carcinoma. World J Gastroenterol (2009) 1.04
Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients. Oncologist (2011) 1.04
Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma. World J Surg Oncol (2008) 1.03
Standard radical gastrectomy in octogenarians and nonagenarians with gastric cancer: are short-term surgical results and long-term survival substantial? J Gastrointest Surg (2012) 1.02
CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer (2009) 1.02
Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Hum Pathol (2002) 0.98
Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Gung Memorial Hospital. World J Gastroenterol (2005) 0.98
Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A (2012) 0.96
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget (2014) 0.95
Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection. PLoS One (2011) 0.95
N3 subclassification incorporated into the final pathologic staging of gastric cancer: a modified system based on current AJCC staging. Medicine (Baltimore) (2015) 0.94
High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene (2005) 0.93
Local anesthesia with ropivacaine for patients undergoing laparoscopic cholecystectomy. World J Gastroenterol (2009) 0.93
Balloon-assisted enteroscopy with prophylactic polypectomy for Peutz-Jeghers syndrome: experience in Taiwan. Dig Dis Sci (2010) 0.92
Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. Lab Invest (2005) 0.91
Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett (2005) 0.90
Early signet ring cell gastric cancer. Dig Dis Sci (2010) 0.89
Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer. Medicine (Baltimore) (2015) 0.89
Endo-GIA for ligation of dilated cystic duct during laparoscopic cholecystectomy: an alternative, novel, and easy method. J Laparoendosc Adv Surg Tech A (2004) 0.89
Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res (2009) 0.88
K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy. Ann Surg Oncol (2012) 0.88
Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas. Ann Surg Oncol (2011) 0.87
Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg (2005) 0.87
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer. World J Surg Oncol (2012) 0.87
Predictive factors for lymph node metastasis in early gastric cancer. World J Gastroenterol (2010) 0.87
Clinicopathological factors predicting long-term overall survival after hepatectomy for peripheral cholangiocarcinoma. World J Surg (2005) 0.87
Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma. World J Gastroenterol (2010) 0.87
Hepatoid microcarcinoma of the pancreas: a case report and review of the literature. Chang Gung Med J (2012) 0.87
Enterovesical fistula caused by a bladder squamous cell carcinoma. World J Gastroenterol (2009) 0.86
Isolated pancreatic metastasis from rectal cancer: a case report and review of literature. World J Surg Oncol (2010) 0.86
MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells. Evid Based Complement Alternat Med (2012) 0.85
Sonic hedgehog signaling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas (2007) 0.85
Single-incision laparoscopic-assisted jejunostomy tube placement. J Laparoendosc Adv Surg Tech A (2013) 0.84
Identification of a novel actin isoform in hepatocellular carcinoma. Hepatol Res (2006) 0.84
Monitoring radiofrequency ablation with ultrasound Nakagami imaging. Med Phys (2013) 0.83
The Fas-mediated apoptotic pathway in cardiac myxoma. Int J Surg Pathol (2010) 0.83
Hepatic hydatid cysts with superinfection in a non-endemic area in Taiwan. Am J Trop Med Hyg (2002) 0.83
Improved hepatocyte function of future liver remnant of cirrhotic rats after portal vein ligation: a bonus other than volume shifting. Surgery (2009) 0.82
Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma. Ann Surg (2004) 0.82
Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol (2007) 0.82
Melatonin prevents hemorrhagic shock-induced liver injury in rats through an Akt-dependent HO-1 pathway. J Pineal Res (2012) 0.81
Profiling of gene expression associated with hepatolithiasis by complementary DNA expression array. Int J Oncol (2003) 0.81
Single-incision laparoscopic-assisted surgery for small bowel obstruction. J Laparoendosc Adv Surg Tech A (2012) 0.81
A useful model to audit liver resolution from cirrhosis in rats using functional proteomics. J Surg Res (2007) 0.80
MUC1, MUC2 and MUC5AC expressions in cardiac myxoma. Virchows Arch (2004) 0.80
Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors. Oncotarget (2014) 0.79
Overexpression of kappa-actin alters growth properties of hepatoma cells and predicts poor postoperative prognosis. Anticancer Res (2011) 0.79
Alterations of the mTOR pathway in hepatic angiomyolipoma with emphasis on the epithelioid variant and loss of heterogeneity of TSC1/TSC2. Histopathology (2015) 0.79
Role of Akt/HO-1 pathway in estrogen-mediated attenuation of trauma-hemorrhage-induced lung injury. J Surg Res (2012) 0.79
Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis. Dig Dis Sci (2003) 0.79
Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. PLoS One (2013) 0.78
Long-term results and prognostic factors in resected pancreatic body and tail adenocarcinomas. J Gastrointest Cancer (2013) 0.78
Prognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of Vater. Medicine (Baltimore) (2015) 0.78
Disrupted hepatic adiponectin signaling impairs liver regeneration of steatotic rats. Chang Gung Med J (2011) 0.78
Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma. PLoS One (2013) 0.78
Significance of insulin signaling in liver regeneration triggered by portal vein ligation. J Surg Res (2009) 0.78
Akt pathway is required for oestrogen-mediated attenuation of lung injury in a rodent model of cerulein-induced acute pancreatitis. Injury (2010) 0.77
Impaired liver regeneration of steatotic rats after portal vein ligation: a particular emphasis on (99m)Tc-DISIDA scintigraphy and adiponectin signaling. J Hepatol (2010) 0.77
Thalidomide attenuates tumor growth and preserves fast-twitch skeletal muscle fibers in cholangiocarcinoma rats. Surgery (2007) 0.77
A novel role of the tumor size in pancreatic cancer as an ancillary factor for predicting resectability. J Cancer Res Ther (2014) 0.76
Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma. PLoS One (2012) 0.75
Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer. Medicine (Baltimore) (2016) 0.75
A comparison of methods for estimating quadratic effects in nonlinear structural equation models. Psychol Methods (2012) 0.75
Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib. Medicine (Baltimore) (2015) 0.75
Effectiveness and feasibility of laparoscopic distal pancreatectomy on patients at high anesthetic risk. J Laparoendosc Adv Surg Tech A (2014) 0.75
Long-term relapse-free rurvival rate and predictive factors of idiopathic thrombocytopenic purpura in adults undergoing splenectomy. Biomed J (2013) 0.75
Laparoscopic resection of malignant gastric polyp-with a particular emphasis on localization by laparoscopic ultrasonography. J Laparoendosc Adv Surg Tech A (2003) 0.75
Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy. J Gastroenterol (2012) 0.75
Clinicopathologic features and predictors for survival of mucinous and non-mucinous appendiceal adenocarcinoma. Dig Surg (2008) 0.75
Breast reconstruction with a muscle-sparing free transverse rectus abdominis myocutaneous flap: comparison between immediate and delayed groups. Chang Gung Med J (2004) 0.75
Pancreatic ductal adenocarcinoma presenting with acute and chronic pancreatitis as initial presentation: is prognosis better? A comparison study.. Hepatogastroenterology (2014) 0.75